SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
WILKERSON L JOHN
(Last) (First) (Middle)
C/O GALEN PARTNERS,
680 WASHINGTON BLVD
(Street)
STAMFORD CT 06901
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Quotient Ltd [ QTNT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/30/2021
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 7,329,074 I See Footnote(2)
Ordinary Shares 04/30/2021 M 6,484 A (1) 58,672 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Ordinary Shares Option (Right to buy) $11.62 (3) 10/31/2025 Ordinary Shares 7,505 7,505 D
Ordinary Shares Option (Right to buy) $8 (4) 04/29/2024 Ordinary Shares 3,500 3,500 D
Ordinary Shares Option (Right to buy) $9.95 (5) 10/31/2024 Ordinary Shares 5,025 5,025 D
Ordinary Shares Option (Right to buy) $5.73 (6) 10/31/2026 Ordinary Shares 8,726 8,726 D
Ordinary Shares Option (Right to buy) $5.21 (7) 10/31/2027 Ordinary Shares 9,597 9,597 D
Ordinary Shares Option (Right to buy) $6.41 (8) 10/31/2028 Ordinary Shares 6,240 6,240 D
Ordinary Shares Option (Right to buy) $7.78 (9) 10/31/2029 Ordinary Shares 8,158 8,158 D
Restricted Stock Units (1) 04/30/2021 M 6,044 (10) (10) Ordinary Shares 6,044 $0.00 12,088 D
Restricted Stock Units (1) 04/30/2021 M 440 (11) (11) Ordinary Shares 440 $0.00 878 D
Ordinary Share Option (Right to Buy) $4.55 (12) 10/31/2030 Ordinary Shares 13,611 13,611 D
Explanation of Responses:
1. Restricted Stock Units convert into ordinary shares on a one-for-one basis.
2. Includes 6,613,590 ordinary shares held of record by Galen V, 564,780 ordinary shares held by Galen International V, and 150,704 ordinary shares held of record by Galen Management, LLC. Mr. Wilkerson is amanaging director of Galen Management, LLC, and shares voting and dispositive power over the securities held by Galen V, Galen International V and Galen Management, LLC. The Reporting Person disclaimsbeneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
3. All 7,505 options have vested and remain exercisable.
4. All 3,500 options have vested and remain exercisable.
5. All 5,025 options have vested and remain exercisable.
6. All 8,726 options have vested and remain exercisable.
7. All 9,597 options have vested and remain exercisable.
8. 4,160 options have vested and remain exercisable, and 2,080 options will vest on October 31, 2021.
9. 2,719 options vested on October 31, 2020 and remain exercisable, and the remaining 5,439 options will vest in two equal annual installments on October 31, 2021 and October 31, 2022.
10. On October 31, 2020, the Reporting Person was granted 24,176 restricted stock units, of which 12,088 have vested and have been exercised. The remaining 12,088 restricted stock units will vest in two equal installments on July 31, 2021 and October 31, 2021.
11. On October 31, 2020, the Reporting Person was granted 1,758 restricted stock units, of which 880 have vested and have been exercised. The remaining 878 restricted stock units will vest in two equal installments on July 31, 2021 and October 31, 2021.
12. The options vest and become exercisable on October 31, 2021.
Remarks:
/s/ John L. Wilkerson 05/03/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.